Kareithi, Tabitha
Roche, Stephanie D.
Meisner, Allison
Omollo, Victor
Ong’wen, Patricia A.
Harkey, Kendall
Kiptinness, Catherine
Otieno, Peris
Juma, Lawrence
Malen, Rachel C.
Anyona, Micah O.
Curran, Kelly
Banerjee, Preetika
Gichuru, Eunice
Asewe, Magdaline
Yu, Kaiyue
Pintye, Jillian
Mugambi, Melissa L.
Shah, Parth D.
Sharma, Monisha
Were, Daniel
Ngure, Kenneth
Bukusi, Elizabeth A.
Ortblad, Katrina F. https://orcid.org/0000-0002-5675-8836
,
Funding for this research was provided by:
Bill and Melinda Gates Foundation (INV-033052)
National Institute of Mental Health (R00 MH121166)
Article History
Received: 5 February 2025
Accepted: 9 December 2025
First Online: 30 December 2025
Declarations
:
: The trial protocol (version 2.1, December 18, 2024), informed consent scripts, surveys and interview guides, and recruitment materials have all been approved by the Scientific Ethics Review Unit at KEMRI (Nairobi, Kenya) and the Institutional Review Board at Fred Hutch (Seattle, USA) (Additional files 4, 5, and 6). All participants provide informed consent prior to enrollment. Consent for clients is verbal and conducted over the phone with a research assistant following a consent script; consent for all provider types is written. In the consent forms, we clarify that study data may be used in future studies, and study participation is optional and may be discontinued at any point. Any potential protocol modifications will be reviewed and approved by our ethics boards before implementation.
: Not applicable.
: The authors declare that they have no competing interests.